{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:28:40Z","timestamp":1793467720887,"version":"4.5.0"},"reference-count":115,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CTMC"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Nature has provided therapeutic substances for millennia, with many valuable medications\nderived from plant sources. Multitarget drugs become essential in the management of various\ndisorders, including hepatic disorders, neurological disorders, diabetes, and carcinomas. Ferulic\nacid is a significant potential therapeutic agent, which is easily available at low cost, possesses a\nlow toxicity profile, and has minimum side effects. Ferulic acid exhibits various therapeutic actions\nby modulation of various signal transduction pathways such as Nrf2, p38, and mTOR. The actions\nexhibited by ferulic acid include anti-apoptosis, antioxidant, anti-inflammatory, antidiabetic, anticarcinogenic,\nhepatoprotection, cardioprotection, activation of transcriptional factors, expression of\ngenes, regulation of enzyme activity, and neuroprotection, which further help in treating various\npathophysiological conditions such as cancer, skin diseases, brain disorders, diabetes, Parkinson\u2019s\ndisease, Alzheimer\u2019s disease, hypoxia, hepatic disorders, H1N1 flu, and viral infections. The current\nreview focuses on the significance of natural products as sources of multitarget compounds,\nand a primary focus has been made on ferulic acid and its mechanism, role, and protective action in\nvarious ailments.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1568026622666220117105740","type":"journal-article","created":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T16:32:26Z","timestamp":1642523546000},"page":"347-365","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Natural Products as Sources of Multitarget Compounds: Advances in the\nDevelopment of Ferulic Acid as Multitarget Therapeutic"],"prefix":"10.2174","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1697-9562","authenticated-orcid":true,"given":"Rajwinder","family":"Kaur","sequence":"first","affiliation":[{"name":"Chitkara College of Pharmacy, Chitkara University, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Sood","sequence":"additional","affiliation":[{"name":"Chitkara College of Pharmacy, Chitkara University, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damanpreet Kaur","family":"Lang","sequence":"additional","affiliation":[{"name":"Chitkara College of Pharmacy, Chitkara University, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Arora","sequence":"additional","affiliation":[{"name":"Chitkara College of Pharmacy, Chitkara University, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Regulatory Affairs, National Institute\nof Pharmaceutical Education and Research (NIPER), Hyderabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Diwan","sequence":"additional","affiliation":[{"name":"Centre for Chronic Disease, The University\nof Queensland, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balraj","family":"Saini","sequence":"additional","affiliation":[{"name":"Chitkara College of Pharmacy, Chitkara University, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.drudis.2008.07.004","volume":"13","author":"Harvey A.L.","year":"2008","unstructured":"Harvey A.L.; Natural products in drug discovery. Drug Discov Today 2008,13(19-20),894-901","journal-title":"Drug Discov Today"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3389\/fphar.2015.00205","volume":"6","author":"Talevi A.","year":"2015","unstructured":"Talevi A.; Multi-target pharmacology: Possibilities and limitations of the \u201cskeleton key approach\u201d from a medicinal chemist perspective. Front Pharmacol 2015,6,205","journal-title":"Front Pharmacol"},{"key":"ref=3","first-page":"89","author":"Weiser T.","year":"2004","unstructured":"Weiser T.;  Drugs that target ionotropic excitatory amino acid receptors In Cognitive Enhancing Drugs 2004,89-96","journal-title":"Drugs that target ionotropic excitatory amino acid receptors In Cognitive Enhancing Drugs"},{"key":"ref=4","unstructured":"US Preventive Services Task Force. Final recommendation statement. Aspirin use to prevent cardiovascular disease and colorectal cancer: Preventive medication. Available from:"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1182\/blood-2009-02-205153","volume":"114","author":"Assouline S.","year":"2009","unstructured":"Assouline S.; Culjkovic B.; Cocolakis E.; Rousseau C.; Beslu N.; Amri A.; Caplan S.; Leber B.; Roy D.C.; Miller W.H. Jr.; Borden K.L.; Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): A proof-of-principle clinical trial with ribavirin. Blood 2009,114(2),257-260","journal-title":"Blood"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2147\/DDDT.S151860","volume":"12","author":"Li J.","year":"2018","unstructured":"Li J.; Yu H.; Wang S.; Wang W.; Chen Q.; Ma Y.; Zhang Y.; Wang T.; Natural products, an important resource for discovery of multitarget drugs and functional food for regulation of hepatic glucose metabolism. Drug Des Devel Ther 2018,12,121-135","journal-title":"Drug Des Devel Ther"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"134","DOI":"10.2174\/1570159X14666160620102055","volume":"15","author":"Chen H.S.","year":"2017","unstructured":"Chen H.S.; Qi S.H.; Shen J.G.; One-compound-multi-target: Combination prospect of natural compounds with thrombolytic therapy in acute ischemic stroke. Curr Neuropharmacol 2017,15(1),134-156","journal-title":"Curr Neuropharmacol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.2174\/0929867311320130007","volume":"20","author":"Chen X.","year":"2013","unstructured":"Chen X.; Decker M.; Multi-target compounds acting in the central nervous system designed from natural products. Curr Med Chem 2013,20(13),1673-1685","journal-title":"Curr Med Chem"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/medicines6010006","volume":"6","author":"Herranz-L\u00f3pez M.","year":"2018","unstructured":"Herranz-L\u00f3pez M.; Losada-Echeberr\u00eda M.; Barraj\u00f3n-Catal\u00e1n E.; The multitarget activity of natural extracts on cancer: Synergy and xenohormesis. Medicines (Basel) 2018,6(1),6","journal-title":"Medicines (Basel)"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3390\/ph13090242","volume":"13","author":"Martins M.","year":"2020","unstructured":"Martins M.; Silva R.; Pinto M.; Sousa E.; Marine natural products, multitarget therapy and repurposed agents in Alzheimer\u2019s disease. Pharmaceuticals (Basel) 2020,13(9),242","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.biopha.2018.05.142","volume":"105","author":"Kumar M.S.","year":"2018","unstructured":"Kumar M.S.; Adki K.M.; Marine natural products for multi-targeted cancer treatment: A future insight. Biomed Pharmacother 2018,105,233-245","journal-title":"Biomed Pharmacother"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3390\/md17090491","volume":"17","author":"Khalifa S.A.M.","year":"2019","unstructured":"Khalifa S.A.M.; Elias N.; Farag M.A.; Chen L.; Saeed A.; Hegazy M.F.; Moustafa M.S.; Abd El-Wahed A.; Al-Mousawi S.M.; Musharraf S.G.; Chang F.R.; Iwasaki A.; Suenaga K.; Alajlani M.; G\u00f6ransson U.; El-Seedi H.R.; Marine natural products: A source of novel anticancer drugs. Mar Drugs 2019,17(9),491","journal-title":"Mar Drugs"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1016\/j.bbagen.2013.02.008","volume":"1830","author":"Cragg G.M.","year":"2013","unstructured":"Cragg G.M.; Newman D.J.; Natural products: A continuing source of novel drug leads. Biochim Biophys Acta, 2013,1830(6),3670-3695","journal-title":"Biochim Biophys Acta,"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3390\/pr8040470","volume":"8","author":"Abdel-Razek A.S.","year":"2020","unstructured":"Abdel-Razek A.S.; El-Naggar M.E.; Allam A.; Morsy O.M.; Othman S.I.; Microbial natural products in drug discovery. Processes (Basel) 2020,8(4),470","journal-title":"Processes (Basel)"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.btre.2014.09.002","volume":"4","author":"Kumar N.","year":"2014","unstructured":"Kumar N.; Pruthi V.; Potential applications of ferulic acid from natural sources. Biotechnol Rep 2014,4,86-93","journal-title":"Biotechnol Rep"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"119921","DOI":"10.1016\/j.lfs.2021.119921","volume":"284","author":"Li D.","year":"2021","unstructured":"Li D.; Rui Y.X.; Guo S.D.; Luan F.; Liu R.; Zeng N.; Ferulic acid: A review of its pharmacology, pharmacokinetics and derivatives. Life Sci 2021,284,119921","journal-title":"Life Sci"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1002\/jsfa.1873","volume":"84","author":"Ou S.","year":"2004","unstructured":"Ou S.; Kwok K.C.; Ferulic acid: Pharmaceutical functions, preparation, and applications in foods. J Sci Food Agric 2004,84(11),1261-1269","journal-title":"J Sci Food Agric"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1159\/000491755","volume":"31","author":"Zdu\u0144ska K.","year":"2018","unstructured":"Zdu\u0144ska K.; Dana A.; Kolodziejczak A.; Rotsztejn H.; Antioxidant properties of ferulic acid and its possible application. Skin Pharmacol Physiol 2018,31(6),332-336","journal-title":"Skin Pharmacol Physiol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10522-008-9160-8","volume":"10","author":"Barone E.","year":"2009","unstructured":"Barone E.; Calabrese V.; Mancuso C.; Ferulic acid and its therapeutic potential as a hormetin for age-related diseases. Biogerontology 2009,10(2),97-108","journal-title":"Biogerontology"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1093\/jn\/134.11.3083","volume":"134","author":"Zhao Z.","year":"2004","unstructured":"Zhao Z.; Egashira Y.; Sanada H.; Ferulic acid is quickly absorbed from rat stomach as the free form and then conjugated mainly in liver. J Nutr 2004,134(11),3083-3088","journal-title":"J Nutr"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1124\/dmd.107.017558","volume":"36","author":"Poquet L.","year":"2008","unstructured":"Poquet L.; Clifford M.N.; Williamson G.; Transport and metabolism of ferulic acid through the colonic epithelium. Drug Metab Dispos 2008,36(1),190-197","journal-title":"Drug Metab Dispos"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"108753","DOI":"10.1016\/j.biopha.2019.108753","volume":"113","author":"Ma Y.","year":"2019","unstructured":"Ma Y.; Chen K.; Lv L.; Wu S.; Guo Z.; Ferulic acid ameliorates nonalcoholic fatty liver disease and modulates the gut microbiota composition in high-fat diet fed ApoE mice. Biomed Pharmacother 2019,113,108753","journal-title":"Biomed Pharmacother"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"4681","DOI":"10.3390\/molecules19044681","volume":"19","author":"Liang C.P.","year":"2014","unstructured":"Liang C.P.; Chang C.H.; Liang C.C.; Hung K.Y.; Hsieh C.W.; \nIn vitro antioxidant activities, free radical scavenging capacity, and tyrosinase inhibitory of flavonoid compounds and ferulic acid from Spiranthes sinensis (Pers.) Ames. Molecules 2014,19(4),4681-4694","journal-title":"Molecules"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3389\/fphar.2020.00376","volume":"11","author":"He S.","year":"2020","unstructured":"He S.; Guo Y.; Zhao J.; Xu X.; Wang N.; Liu Q.; Ferulic acid ameliorates lipopolysaccharide-induced barrier dysfunction via microRNA-200c-3p-mediated activation of PI3K\/AKT pathway in Caco-2 cells. Front Pharmacol 2020,11,376","journal-title":"Front Pharmacol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/B978-0-444-64056-7.00013-1","volume":"58","author":"Al Jitan S.","year":"2018","unstructured":"Al Jitan S.; Alkhoori S.A.; Yousef L.F.; Phenolic acids from plants: Extraction and application to human health. Stud Nat Prod Chem 2018,58,389-417","journal-title":"Stud Nat Prod Chem"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"102978","DOI":"10.1016\/j.jcs.2020.102978","volume":"93","author":"\u00c7elik E.E.","year":"2020","unstructured":"\u00c7elik E.E.; G\u00f6kmen V.; Effects of fermentation and heat treatment on bound ferulic acid content and total antioxidant capacity of bread crust-like systems made of different whole grain flours. J Cereal Sci 2020,93,102978","journal-title":"J Cereal Sci"},{"key":"ref=27","unstructured":"ClinicalTrilas.gov. Available from:  [Accessed on 25 June, 2021]."},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.fct.2017.02.028","volume":"103","author":"Ghosh S.","year":"2017","unstructured":"Ghosh S.; Basak P.; Dutta S.; Chowdhury S.; Sil P.C.; New insights into the ameliorative effects of ferulic acid in pathophysiological conditions. Food Chem Toxicol 2017,103,41-55","journal-title":"Food Chem Toxicol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3389\/fphar.2020.00103","volume":"11","author":"Luo C.","year":"2020","unstructured":"Luo C.; Zhang Y.; Guo H.; Han X.; Ren J.; Liu J.; Ferulic acid attenuates hypoxia\/reoxygenation injury by suppressing mitophagy through the PINK1\/Parkin Signaling Pathway in H9c2 Cells. Front Pharmacol 2020,11,103","journal-title":"Front Pharmacol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"202","DOI":"10.4103\/0973-1296.113264","volume":"9","author":"Ren C.","year":"2013","unstructured":"Ren C.; Bao Y.R.; Meng X.S.; Diao Y.P.; Kang T.G.; Comparison of the protective effects of ferulic acid and its drug-containing plasma on primary cultured neonatal rat cardiomyocytes with hypoxia\/reoxygenation injury. Pharmacogn Mag 2013,9(35),202-209","journal-title":"Pharmacogn Mag"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"e0228825","DOI":"10.1371\/journal.pone.0228825","volume":"15","author":"Yao K.","year":"2020","unstructured":"Yao K.; Yang Q.; Li Y.; Lan T.; Yu H.; Yu Y.; MicroRNA-9 mediated the protective effect of ferulic acid on hypoxic-ischemic brain damage in neonatal rats. PLoS One 2020,15(5),e0228825","journal-title":"PLoS One"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1055\/s-2006-958060","volume":"61","author":"Hirabayashi T.","year":"1995","unstructured":"Hirabayashi T.; Ochiai H.; Sakai S.; Nakajima K.; Terasawa K.; Inhibitory effect of ferulic acid and isoferulic acid on murine interleukin-8 production in response to influenza virus infections in vitro and in vivo. Planta Med 1995,61(3),221-226","journal-title":"Planta Med"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/09629359990513","volume":"8","author":"Sakai S.","year":"1999","unstructured":"Sakai S.; Kawamata H.; Kogure T.; Mantani N.; Terasawa K.; Umatake M.; Ochiai H.; Inhibitory effect of ferulic acid and isoferulic acid on the production of macrophage inflammatory protein-2 in response to respiratory syncytial virus infection in RAW264.7 cells. Mediators Inflamm 1999,8(3),173-175","journal-title":"Mediators Inflamm"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.pcad.2020.02.007","volume":"63","author":"McCarty M.F.","year":"2020","unstructured":"McCarty M.F.; DiNicolantonio J.J.; Nutraceuticals have potential for boosting the type 1 interferon response to RNA viruses including influenza and coronavirus. Prog Cardiovasc Dis 2020,63(3),383-385","journal-title":"Prog Cardiovasc Dis"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.bbrc.2019.03.113","volume":"512","author":"Zhu Y.","year":"2019","unstructured":"Zhu Y.; Shao Y.; Qu X.; Guo J.; Yang J.; Zhou Z.; Wang S.; Sodium ferulate protects against influenza virus infection by activation of the TLR7\/9-MyD88-IRF7 signaling pathway and inhibition of the NF-\u03baB signaling pathway. Biochem Biophys Res Commun 2019,512(4),793-798","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"104451","DOI":"10.1016\/j.meegid.2020.104451","volume":"84","author":"Bhowmik D.","year":"2020","unstructured":"Bhowmik D.; Nandi R.; Jagadeesan R.; Kumar N.; Prakash A.; Kumar D.; Identification of potential inhibitors against SARS- CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches. Infect Genet Evol 2020,84,104451","journal-title":"Infect Genet Evol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s13659-020-00271-z","volume":"10","author":"Khalil A.","year":"2020","unstructured":"Khalil A.; Tazeddinova D.; The upshot of polyphenolic compounds on immunity amid COVID-19 pandemic and other emerging communicable diseases: An appraisal. Nat Prod Bioprospect 2020,10(6),411-429","journal-title":"Nat Prod Bioprospect"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"e1900174","DOI":"10.1002\/ardp.201900174","volume":"353","author":"Cui M.Y.","year":"2020","unstructured":"Cui M.Y.; Xiao M.W.; Xu L.J.; Chen Y.; Liu A.L.; Ye J.; Hu A.X.; Bioassay of ferulic acid derivatives as influenza neuraminidase inhibitors. Arch Pharm (Weinheim) 2020,353(1),e1900174","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.sjbs.2015.01.011","volume":"22","author":"Enkhtaivan G.","year":"2015","unstructured":"Enkhtaivan G.; Maria John K.M.; Ayyanar M.; Sekar T.; Jin K.J.; Kim D.H.; Anti-influenza (H1N1) potential of leaf and stem bark extracts of selected medicinal plants of South India. Saudi J Biol Sci 2015,22(5),532-538","journal-title":"Saudi J Biol Sci"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"38692","DOI":"10.1038\/srep38692","volume":"6","author":"Hariono M.","year":"2016","unstructured":"Hariono M.; Abdullah N.; Damodaran K.V.; Kamarulzaman E.E.; Mohamed N.; Hassan S.S.; Shamsuddin S.; Wahab H.A.; Potential new H1N1 neuraminidase inhibitors from ferulic acid and vanillin: Molecular modelling, synthesis, and in vitro assay. Sci Rep 2016,6(1),38692","journal-title":"Sci Rep"},{"key":"ref=41","doi-asserted-by":"publisher","DOI":"10.2174\/1874091X01913010013","volume":"13","author":"Adeyemi O.S.","year":"2019","unstructured":"Adeyemi O.S.; Awakan O.J.; Atolani O.; Iyeye C.O.; Oweibo O.O.; Adejumo O.J.; Ibrahim A.; Batiha G.E.; New ferulic acid derivatives protect against carbon tetrachloride-induced liver injury in rats. Open Biochem J 2019,13(1)","journal-title":"Open Biochem J"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12986-021-00540-9","volume":"18","author":"Xu T.","year":"2021","unstructured":"Xu T.; Song Q.; Zhou L.; Yang W.; Wu X.; Qian Q.; Chai H.; Han Q.; Pan H.; Dou X.; Li S.; Ferulic acid alleviates lipotoxicity-induced hepatocellular death through the SIRT1-regulated autophagy pathway and independently of AMPK and Akt in AML-12 hepatocytes. Nutr Metab (Lond) 2021,18(1),13","journal-title":"Nutr Metab (Lond)"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3389\/fphar.2019.00509","volume":"10","author":"Saha P.","year":"2019","unstructured":"Saha P.; Talukdar A.D.; Nath R.; Sarker S.D.; Nahar L.; Sahu J.; Choudhury M.D.; Role of natural phenolics in hepatoprotection: A mechanistic review and analysis of the regulatory network of associated genes. Front Pharmacol 2019,10,509","journal-title":"Front Pharmacol"},{"key":"ref=44","first-page":"2228","volume":"15","author":"Yang C.","year":"2018","unstructured":"Yang C.; Li L.; Ma Z.; Zhong Y.; Pang W.; Xiong M.; Fang S.; Li Y.; Hepatoprotective effect of methyl ferulic acid against carbon tetrachloride-induced acute liver injury in rats. Exp Ther Med 2018,15(3),2228-2238","journal-title":"Exp Ther Med"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.cbi.2018.12.006","volume":"299","author":"Cheng Q.","year":"2019","unstructured":"Cheng Q.; Li C.; Yang C.F.; Zhong Y.J.; Wu D.; Shi L.; Chen L.; Li Y.W.; Li L.; Methyl ferulic acid attenuates liver fibrosis and hepatic stellate cell activation through the TGF-\u03b21\/Smad and NOX4\/ROS pathways. Chem Biol Interact 2019,299,131-139","journal-title":"Chem Biol Interact"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.2147\/DDDT.S186726","volume":"12","author":"Mu M.","year":"2018","unstructured":"Mu M.; Zuo S.; Wu R.M.; Deng K.S.; Lu S.; Zhu J.J.; Zou G.L.; Yang J.; Cheng M.L.; Zhao X.K.; Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-\u03b2\/Smad signaling pathway. Drug Des Devel Ther 2018,12,4107-4115","journal-title":"Drug Des Devel Ther"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.cbi.2018.06.028","volume":"291","author":"Cheng Q.","year":"2018","unstructured":"Cheng Q.; Li Y.W.; Yang C.F.; Zhong Y.J.; He H.; Zhu F.C.; Li L.; Methyl ferulic acid attenuates ethanol-induced hepatic steatosis by regulating AMPK and FoxO1 Pathways in Rats and L-02 cells. Chem Biol Interact 2018,291,180-189","journal-title":"Chem Biol Interact"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.bbrc.2017.09.030","volume":"493","author":"Li C.","year":"2017","unstructured":"Li C.; Li L.; Yang C.F.; Zhong Y.J.; Wu D.; Shi L.; Chen L.; Li Y.W.; Hepatoprotective effects of Methyl ferulic acid on alcohol-induced liver oxidative injury in mice by inhibiting the NOX4\/ROS-MAPK pathway. Biochem Biophys Res Commun 2017,493(1),277-285","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.3390\/molecules24081596","volume":"24","author":"Ma Y.","year":"2019","unstructured":"Ma Y.; Feng Y.; Zeng W.; Luo H.; Anthocyanin encapsulated by ferulic acid-grafted maltodextrin (FA-g-MD) microcapsules potentially improved its free radical scavenging capabilities against HO-induced oxidative stress. Molecules 2019,24(8),1596","journal-title":"Molecules"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"111978","DOI":"10.1016\/j.fct.2021.111978","volume":"149","author":"Wang Z.","year":"2021","unstructured":"Wang Z.; Yang Y.; Zhang J.; Hu J.; Yan X.; Zeng S.; Huang X.; Lin S.; Ferulic acid ameliorates intrahepatic triglyceride accumulation in vitro but not in high fat diet-fed C57BL\/6 mice. Food Chem Toxicol 2021,149,111978","journal-title":"Food Chem Toxicol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.2174\/1381612822666161208145508","volume":"23","author":"Damasceno S.S.","year":"2017","unstructured":"Damasceno S.S.; Dantas B.B.; Ribeiro-Filho J.; Ant\u00f4nio, M.; Ara\u00fajo D.; Galberto M da Costa J.; Chemical properties of caffeic and ferulic acids in the biological systems: Implications in cancer therapy. A review. Curr Pharm Des 2017,23(20),3015-3023","journal-title":"Curr Pharm Des"},{"key":"ref=52","first-page":"968","volume":"8","author":"Wang T.","year":"2016","unstructured":"Wang T.; Gong X.; Jiang R.; Li H.; Du W.; Kuang G.; Ferulic acid inhibits proliferation and promotes apoptosis via blockage of PI3K\/Akt pathway in osteosarcoma cell. Am J Transl Res 2016,8(2),968-980","journal-title":"Am J Transl Res"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s10529-017-2475-2","volume":"40","author":"Sudhagar S.","year":"2018","unstructured":"Sudhagar S.; Sathya S.; Anuradha R.; Gokulapriya G.; Geetharani Y.; Lakshmi B.S.; Inhibition of epidermal growth factor receptor by ferulic acid and 4-vinylguaiacol in human breast cancer cells. Biotechnol Lett 2018,40(2),257-262","journal-title":"Biotechnol Lett"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-018-0595-y","volume":"18","author":"Gao J.","year":"2018","unstructured":"Gao J.; Yu H.; Guo W.; Kong Y.; Li Q.; Yang S.; Zhang Y.; Wang Y.; The anticancer effect of ferulic acid are associated with the induction of cell cycle arrest and autophagy in cervical cancer cells. Cancer Cell Int 2018,18(1),1-9","journal-title":"Cancer Cell Int"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1016\/j.fct.2010.09.006","volume":"48","author":"Maurya D.K.","year":"2010","unstructured":"Maurya D.K.; Devasagayam T.P.; Antioxidant and prooxidant nature of hydroxycinnamic acid derivatives ferulic and caffeic acids. Food Chem Toxicol 2010,48(12),3369-3373","journal-title":"Food Chem Toxicol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.tiv.2003.12.012","volume":"18","author":"Azam S.","year":"2004","unstructured":"Azam S.; Hadi N.; Khan N.U.; Hadi S.M.; Prooxidant property of green tea polyphenols epicatechin and epigallocatechin-3-gallate: Implications for anticancer properties. Toxicol In Vitro 2004,18(5),555-561","journal-title":"Toxicol In Vitro"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"110999","DOI":"10.1016\/j.jinorgbio.2020.110999","volume":"205","author":"Pellerito C.","year":"2020","unstructured":"Pellerito C.; Emanuele S.; Ferrante F.; Celesia A.; Giuliano M.; Fiore T.; Tributyltin(IV) ferulate, a novel synthetic ferulic acid derivative, induces autophagic cell death in colon cancer cells: From chemical synthesis to biochemical effects. J Inorg Biochem 2020,205,110999","journal-title":"J Inorg Biochem"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"8135","DOI":"10.3390\/ijms21218135","volume":"21","author":"Celesia A.","year":"2020","unstructured":"Celesia A.; Morana O.; Fiore T.; Pellerito C.; D\u2019Anneo A.; Lauricella M.; Carlisi D.; De Blasio A.; Calvaruso G.; Giuliano M.; Emanuele S.; ROS-dependent ER stress and autophagy mediate the anti-tumor effects of tributyltin (IV) Ferulate in colon cancer cells. Int J Mol Sci 2020,21(21),8135","journal-title":"Int J Mol Sci"},{"key":"ref=59","first-page":"4019","volume":"17","author":"Roy N.","year":"2016","unstructured":"Roy N.; Narayanankutty A.; Nazeem P.A.; Valsalan R.; Babu T.D.; Mathew D.; Plant phenolics, ferulic acid, and p-coumaric acid inhibit colorectal cancer cell proliferation through EGFR downregulation. Asian Pac J Cancer Prev 2016,17(8),4019-4023","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"115424","DOI":"10.1016\/j.bmc.2020.115424","volume":"28","author":"Aneja B.","year":"2020","unstructured":"Aneja B.; Queen A.; Khan P.; Shamsi F.; Hussain A.; Hasan P.; Rizvi M.M.A.; Daniliuc C.G.; Alajmi M.F.; Mohsin M.; Hassan M.I.; Abid M.; Design, synthesis","journal-title":"Bioorg Med Chem"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1016\/j.bmc.2014.03.019","volume":"22","author":"Lu W.","year":"2014","unstructured":"Lu W.; Wang F.; Zhang T.; Dong J.; Gao H.; Su P.; Shi Y.; Zhang J.; Search for novel histone deacetylase inhibitors. Part II: Design and synthesis of novel isoferulic acid derivatives. Bioorg Med Chem 2014,22(9),2707-2713","journal-title":"Bioorg Med Chem"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/mds.28075","volume":"36","author":"Hirsch E.C.","year":"2021","unstructured":"Hirsch E.C.; Standaert D.G.; Ten unsolved questions about neuroinflammation in Parkinson\u2019s disease. Mov Disord 2021,36(1),16-24","journal-title":"Mov Disord"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1017\/S135561771700100X","volume":"23","author":"Bondi M.W.","year":"2017","unstructured":"Bondi M.W.; Edmonds E.C.; Salmon D.P.; Alzheimer\u2019s disease: Past, present, and future.  J Int Neuropsychol Soc 2017,23(9-10),818-831","journal-title":"J Int Neuropsychol Soc"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"5764","DOI":"10.3390\/nu7075246","volume":"7","author":"Sgarbossa A.","year":"2015","unstructured":"Sgarbossa A.; Giacomazza D.; di Carlo M.; Ferulic acid: A hope for Alzheimer\u2019s disease therapy from plants. Nutrients 2015,7(7),5764-5782","journal-title":"Nutrients"},{"key":"ref=65","first-page":"575","author":"Kaur S.","year":"2018","unstructured":"Kaur S.; Dhiman M.; Mantha A.K.;  Ferulic Acid: A Natural Antioxidant with Application Towards Neuroprotection Against Alzheimer\u2019s Disease InFunctional Food and Human Health 2018,575-586","journal-title":"Ferulic Acid: A Natural Antioxidant with Application Towards Neuroprotection Against Alzheimer\u2019s Disease InFunctional Food and Human Health"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.bbadis.2011.10.015","volume":"1822","author":"Sultana R.","year":"2012","unstructured":"Sultana R.; Ferulic acid ethyl ester as a potential therapy in neurodegenerative disorders. Biochim Biophys Acta 2012,1822(5),748-752","journal-title":"Biochim Biophys Acta"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"S548","DOI":"10.1016\/j.jalz.2010.05.1828","volume":"4","author":"Kanaya K.","year":"2010","unstructured":"Kanaya K.; Effects of ferulic acid and Angelica archangelica extract (Feruguard) in patients with Alzheimer\u2019s disease. Alzheimers Dement 2010,4(6),S548","journal-title":"Alzheimers Dement"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"e55774","DOI":"10.1371\/journal.pone.0055774","volume":"8","author":"Mori T.","year":"2013","unstructured":"Mori T.; Koyama N.; Guillot-Sestier M.V.; Tan J.; Town T.; Ferulic acid is a nutraceutical \u03b2-secretase modulator that improves behavioral impairment and alzheimer-like pathology in transgenic mice. PLoS One 2013,8(2),e55774","journal-title":"PLoS One"},{"key":"ref=69","first-page":"1","author":"Kudoh C.","year":"2020","unstructured":"Kudoh C.; Hori T.; Yasaki S.; Ubagai R.; Tabira T.; Effects of ferulic acid and angelica archangelica extract (Feru-guard\u00ae) on mild cognitive impairment: A multicenter, randomized, double-blind, placebo-controlled prospective trial. J Alzheimer's Dis 2020,1-6","journal-title":"J Alzheimer's Dis"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"11310","DOI":"10.1074\/jbc.M116.762658","volume":"292","author":"Mori T.","year":"2017","unstructured":"Mori T.; Koyama N.; Tan J.; Segawa T.; Maeda M.; Town T.; Combination therapy with octyl gallate and ferulic acid improves cognition and neurodegeneration in a transgenic mouse model of Alzheimer\u2019s disease. J Biol Chem 2017,292(27),11310-11325","journal-title":"J Biol Chem"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"3528148","DOI":"10.1155\/2019\/3528148","volume":"2019","author":"Montaser A.","year":"2019","unstructured":"Montaser A.; Huttunen J.; Ibrahim S.A.; Huttunen K.M.; Astrocyte-targeted transporter-utilizing derivatives of ferulic acid can have multifunctional effects ameliorating inflammation and oxidative stress in the brain. Oxid Med Cell Longev 2019,2019,3528148","journal-title":"Oxid Med Cell Longev"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"8590578","DOI":"10.1155\/2016\/8590578","volume":"2016","author":"Manoharan S.","year":"2016","unstructured":"Manoharan S.; Guillemin G.J.; Abiramasundari R.S.; Essa M.M.; Akbar M.; Akbar M.D.; The role of reactive oxygen species in the pathogenesis of Alzheimer\u2019s disease, Parkinson\u2019s disease, and Huntington\u2019s disease: A mini review. Oxid Med Cell Longev 2016,2016,8590578","journal-title":"Oxid Med Cell Longev"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/ptr.6523","volume":"34","author":"Anis E.","year":"2020","unstructured":"Anis E.; Zafeer M.F.; Firdaus F.; Islam S.N.; Anees Khan A.; Ali A.; Hossain M.M.; Ferulic acid reinstates mitochondrial dynamics through PGC1\u03b1 expression modulation in 6-hydroxydopamine lesioned rats. Phytother Res 2020,34(1),214-226","journal-title":"Phytother Res"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1080\/09168451.2017.1336925","volume":"81","author":"Kikugawa M.","year":"2017","unstructured":"Kikugawa M.; Ida T.; Ihara H.; Sakamoto T.; Ferulic acid and its water-soluble derivatives inhibit nitric oxide production and inducible nitric oxide synthase expression in rat primary astrocytes. Biosci Biotechnol Biochem 2017,81(8),1607-1611","journal-title":"Biosci Biotechnol Biochem"},{"key":"ref=75","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1007\/s12640-019-00099-7","volume":"37","author":"Salau V.F.","year":"2020","unstructured":"Salau V.F.; Erukainure O.L.; Ibeji C.U.; Olasehinde T.A.; Koorbanally N.A.; Islam M.S.; Ferulic acid modulates dysfunctional metabolic pathways and purinergic activity, while stalling redox imbalance and cholinergic activity in oxidative brain injury. Neurotox Res 2020,37(4),944-955","journal-title":"Neurotox Res"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4155\/fmc.14.148","volume":"7","author":"Benchekroun M.","year":"2015","unstructured":"Benchekroun M.; Ismaili L.; Pudlo M.; Luzet V.; Gharbi T.; Refouvelet B.; Marco-Contelles J.; Donepezil-ferulic acid hybrids as anti-Alzheimer drugs. Future Med Chem 2015,7(1),15-21","journal-title":"Future Med Chem"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.bmc.2016.01.010","volume":"24","author":"Fang L.","year":"2016","unstructured":"Fang L.; Chen M.; Liu Z.; Fang X.; Gou S.; Chen L.; Ferulic acid-carbazole hybrid compounds: Combination of cholinesterase inhibition, antioxidant and neuroprotection as multifunctional anti-Alzheimer agents. Bioorg Med Chem 2016,24(4),886-893","journal-title":"Bioorg Med Chem"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1016\/j.bmcl.2016.03.086","volume":"26","author":"Pan W.","year":"2016","unstructured":"Pan W.; Hu K.; Bai P.; Yu L.; Ma Q.; Li T.; Zhang X.; Chen C.; Peng K.; Liu W.; Sang Z.; Design, synthesis and evaluation of novel ferulic acid-memoquin hybrids as potential multifunctional agents for the treatment of Alzheimer\u2019s disease. Bioorg Med Chem Lett 2016,26(10),2539-2543","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ejmech.2017.02.039","volume":"130","author":"Sang Z.","year":"2017","unstructured":"Sang Z.; Pan W.; Wang K.; Ma Q.; Yu L.; Yang Y.; Bai P.; Leng C.; Xu Q.; Li X.; Tan Z.; Liu W.; Design, synthesis and evaluation of novel ferulic acid-O-alkylamine derivatives as potential multifunctional agents for the treatment of Alzheimer\u2019s disease. Eur J Med Chem 2017,130,379-392","journal-title":"Eur J Med Chem"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1021\/acschemneuro.8b00530","volume":"10","author":"Sang Z.","year":"2019","unstructured":"Sang Z.; Wang K.; Han X.; Cao M.; Tan Z.; Liu W.; Design, synthesis, and evaluation of novel ferulic acid derivatives as multitarget-directed ligands for the treatment of Alzheimer\u2019s disease. ACS Chem Neurosci 2019,10(2),1008-1024","journal-title":"ACS Chem Neurosci"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"103413","DOI":"10.1016\/j.bioorg.2019.103413","volume":"94","author":"Lan J.S.","year":"2020","unstructured":"Lan J.S.; Zeng R.F.; Jiang X.Y.; Hou J.W.; Liu Y.; Hu Z.H.; Li H.X.; Li Y.; Xie S.S.; Ding Y.; Zhang T.; Design, synthesis and evaluation of novel ferulic acid derivatives as multi-target-directed ligands for the treatment of Alzheimer\u2019s disease. Bioorg Chem 2020,94,103413","journal-title":"Bioorg Chem"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"103310","DOI":"10.1016\/j.bioorg.2019.103310","volume":"93","author":"Mo J.","year":"2019","unstructured":"Mo J.; Yang H.; Chen T.; Li Q.; Lin H.; Feng F.; Liu W.; Qu W.; Guo Q.; Chi H.; Chen Y.; Sun H.; Design, synthesis, biological evaluation, and molecular modeling studies of quinoline-ferulic acid hybrids as cholinesterase inhibitors. Bioorg Chem 2019,93,103310","journal-title":"Bioorg Chem"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ejmech.2019.07.011","volume":"180","author":"Rosini M.","year":"2019","unstructured":"Rosini M.; Simoni E.; Caporaso R.; Basagni F.; Catanzaro M.; Abu I.F.; Fagiani F.; Fusco F.; Masuzzo S.; Albani D.; Lanni C.; Mellor I.R.; Minarini A.; Merging memantine and ferulic acid to probe connections between NMDA receptors, oxidative stress and amyloid-\u03b2 peptide in Alzheimer\u2019s disease. Eur J Med Chem 2019,180,111-120","journal-title":"Eur J Med Chem"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"103506","DOI":"10.1016\/j.bioorg.2019.103506","volume":"95","author":"Tripathi A.","year":"2020","unstructured":"Tripathi A.; Choubey P.K.; Sharma P.; Seth A.; Saraf P.; Shrivastava S.K.; Design, synthesis, and biological evaluation of ferulic acid based 1,3,4-oxadiazole hybrids as multifunctional therapeutics for the treatment of Alzheimer\u2019s disease. Bioorg Chem 2020,95,103506","journal-title":"Bioorg Chem"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"113278","DOI":"10.1016\/j.ejmech.2021.113278","volume":"215","author":"Singh Y.P.","year":"2021","unstructured":"Singh Y.P.; Rai H.; Singh G.; Singh G.K.; Mishra S.; Kumar S.; Srikrishna S.; Modi G.; A review on ferulic acid and analogs based scaffolds for the management of Alzheimer\u2019s disease. Eur J Med Chem 2021,215,113278","journal-title":"Eur J Med Chem"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"152","DOI":"10.5530\/ijper.51.3s.3","volume":"51","author":"Yapar E.A.","year":"2017","unstructured":"Yapar E.A.; Herbal cosmetics and novel drug delivery systems. Indian J Pharm Educ Res 2017,51(3),152-158","journal-title":"Indian J Pharm Educ Res"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"68","DOI":"10.21705\/mcbs.v4i2.90","volume":"4","author":"Girsang E.","year":"2020","unstructured":"Girsang E.; Lister I.N.; Ginting C.N.; Bethasari M.; Amalia A.; Widowati W.; Comparison of antiaging and antioxidant activities of protocatechuic and ferulic acids. Mol Cell Biomed Sci 2020,4(2),68-75","journal-title":"Mol Cell Biomed Sci"},{"key":"ref=88","first-page":"53","volume":"1","author":"Dr\u0103gan M.","year":"2018","unstructured":"Dr\u0103gan M.; T\u0103t\u0103r\u00eeng\u0103 G.; Mircea C.; Cioanc\u0103 O.; Dragostin O.; Iacob A.T.; Profire L.; Stan C.D.; Ferulic acid-a versatile molecule. ActaBiologicaMarisiensis 2018,1(2),53-60","journal-title":"ActaBiologicaMarisiensis"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"561","DOI":"10.7314\/APJCP.2014.15.2.561","volume":"15","author":"Kruk J.","year":"2014","unstructured":"Kruk J.; Duchnik E.; Oxidative stress and skin diseases: Possible role of physical activity. Asian Pac J Cancer Prev 2014,15(2),561-568","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s12291-012-0278-8","volume":"28","author":"Narendhirakannan R.T.","year":"2013","unstructured":"Narendhirakannan R.T.; Hannah M.A.; Oxidative stress and skin cancer: An overview. Indian J Clin Biochem 2013,28(2),110-115","journal-title":"Indian J Clin Biochem"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.jnutbio.2011.01.009","volume":"23","author":"Staniforth V.","year":"2012","unstructured":"Staniforth V.; Huang W.C.; Aravindaram K.; Yang N.S.; Ferulic acid, a phenolic phytochemical, inhibits UVB-induced matrix metalloproteinases in mouse skin via posttranslational mechanisms. J Nutr Biochem 2012,23(5),443-451","journal-title":"J Nutr Biochem"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0304-3835(00)00478-X","volume":"157","author":"Murakami A.","year":"2000","unstructured":"Murakami A.; Kadota M.; Takahashi D.; Taniguchi H.; Nomura E.; Hosoda A.; Tsuno T.; Maruta Y.; Ohigashi H.; Koshimizu K.; Suppressive effects of novel ferulic acid derivatives on cellular responses induced by phorbol ester, and by combined lipopolysaccharide and interferon-\u03b3. Cancer Lett 2000,157(1),77-85","journal-title":"Cancer Lett"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0304-3835(01)00858-8","volume":"180","author":"Murakami A.","year":"2002","unstructured":"Murakami A.; Nakamura Y.; Koshimizu K.; Takahashi D.; Matsumoto K.; Hagihara K.; Taniguchi H.; Nomura E.; Hosoda A.; Tsuno T.; Maruta Y.; Kim H.W.; Kawabata K.; Ohigashi H.; FA15, a hydrophobic derivative of ferulic acid, suppresses inflammatory responses and skin tumor promotion: Comparison with ferulic acid. Cancer Lett 2002,180(2),121-129","journal-title":"Cancer Lett"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.clindermatol.2008.01.005","volume":"26","author":"Calabrese V.","year":"2008","unstructured":"Calabrese V.; Calafato S.; Puleo E.; Cornelius C.; Sapienza M.; Morganti P.; Mancuso C.; Redox regulation of cellular stress response by ferulic acid ethyl ester in human dermal fibroblasts: Role of vitagenes. Clin Dermatol 2008,26(4),358-363","journal-title":"Clin Dermatol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3164\/jcbn.40.92","volume":"40","author":"Srinivasan M.","year":"2007","unstructured":"Srinivasan M.; Sudheer A.R.; Menon V.P.; Ferulic Acid: Therapeutic potential through its antioxidant property. J Clin Biochem Nutr 2007,40(2),92-100","journal-title":"J Clin Biochem Nutr"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.sjbs.2018.05.028","volume":"26","author":"Dra L.A.","year":"2019","unstructured":"Dra L.A.; Sellami S.; Rais H.; Aziz F.; Aghraz A.; Bekkouche K.; Markouk M.; Larhsini M.; Antidiabetic potential of Caralluma europaea against alloxan-induced diabetes in mice. Saudi J Biol Sci 2019,26(6),1171-1178","journal-title":"Saudi J Biol Sci"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s12020-012-9868-8","volume":"44","author":"Roy S.","year":"2013","unstructured":"Roy S.; Metya S.K.; Sannigrahi S.; Rahaman N.; Ahmed F.; Treatment with ferulic acid to rats with streptozotocin-induced diabetes: Effects on oxidative stress, pro-inflammatory cytokines, and apoptosis in the pancreatic \u03b2 cell. Endocrine 2013,44(2),369-379","journal-title":"Endocrine"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jcjd.2017.05.007","volume":"42","author":"Vellai R.D.","year":"2018","unstructured":"Vellai R.D.; Chandiran S.; Pillai S.S.; GTF-231, a mixture of gymnemic acid, trigonelline, and ferulic acid, significantly ameliorates oxidative stress in experimental type 2 diabetes in rats. Can J Diabetes 2018,42(3),237-244","journal-title":"Can J Diabetes"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.phymed.2012.12.004","volume":"20","author":"Prabhakar P.K.","year":"2013","unstructured":"Prabhakar P.K.; Prasad R.; Ali S.; Doble M.; Synergistic interaction of ferulic acid with commercial hypoglycemic drugs in streptozotocin induced diabetic rats. Phytomedicine 2013,20(6),488-494","journal-title":"Phytomedicine"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"H7","DOI":"10.1111\/j.1750-3841.2010.01907.x","volume":"76","author":"Son M.J.","year":"2011","unstructured":"Son M.J.; Rico C.W.; Nam S.H.; Kang M.Y.; Effect of oryzanol and ferulic acid on the glucose metabolism of mice fed with a high-fat diet. J Food Sci 2011,76(1),H7-H10","journal-title":"J Food Sci"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.biopha.2018.10.152","volume":"110","author":"Latifi E.","year":"2019","unstructured":"Latifi E.; Mohammadpour A.A.; H B.F.; Nourani H.; Antidiabetic and antihyperlipidemic effects of ethanolic Ferula assa-foetida oleo-gum-resin extract in streptozotocin-induced diabetic wistar rats. Biomed Pharmacother 2019,110,197-202","journal-title":"Biomed Pharmacother"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.phymed.2017.10.015","volume":"37","author":"Nankar R.","year":"2017","unstructured":"Nankar R.; Prabhakar P.K.; Doble M.; Hybrid drug combination: Combination of ferulic acid and metformin as anti-diabetic therapy. Phytomedicine 2017,37,10-13","journal-title":"Phytomedicine"},{"key":"ref=103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cmdc.201900683","volume":"15","author":"Yasmin S.","year":"2020","unstructured":"Yasmin S.; Cerchia C.; Badavath V.N.; Laghezza A.; Dal Piaz F.; Mondal S.K.; Atl\u0131 \u00d6.; Baysal M.; Vadivelan S.; Shankar S.; Siddique M.U.; A series of ferulic acid amides revealed unexpected peroxiredoxin 1 inhibitory activity with in vivo antidiabetic and hypolipidemic effects. ChemMedChem 2020,15,1-6","journal-title":"ChemMedChem"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1080\/07391102.2020.1740790","volume":"39","author":"Senthil R.","year":"2021","unstructured":"Senthil R.; Sakthivel M.; Usha S.; Structure-based drug design of peroxisome proliferator-activated receptor gamma inhibitors: Ferulic acid and derivatives. J Biomol Struct Dyn 2021,39(4),1295-1311","journal-title":"J Biomol Struct Dyn"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"109191","DOI":"10.1016\/j.eurpolymj.2019.08.018","volume":"120","author":"Prajapati S.K.","year":"2019","unstructured":"Prajapati S.K.; Jain A.; Jain A.; Jain S.; Biodegradable polymers and constructs: A novel approach in drug delivery. Eur Polym J 2019,120,109191","journal-title":"Eur Polym J"},{"key":"ref=106","first-page":"225","volume":"45","author":"Goyal A.","year":"2011","unstructured":"Goyal A.; Kumar S.; Nagpal M.; Singh I.; Arora S.; Potential of novel drug delivery systems for herbal drugs. Ind J Pharm Education Res 2011,45(3),225-235","journal-title":"Ind J Pharm Education Res"},{"key":"ref=107","first-page":"91","volume":"32","author":"Singh I.","year":"2007","unstructured":"Singh I.; Rehni A.K.; Kalra R.; Joshi G.; Kumar M.; Aboul-Enein H.Y.; Ion exchange resins: Drug delivery and therapeutic applications. Fabad J Pharm Sci 2007,32(2),91","journal-title":"Fabad J Pharm Sci"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3390\/pharmaceutics13050687","volume":"13","author":"Romeo A.","year":"2021","unstructured":"Romeo A.; Musumeci T.; Carbone C.; Bonaccorso A.; Corvo S.; Lupo G.; Anfuso C.D.; Puglisi G.; Pignatello R.; Ferulic acid-loaded polymeric nanoparticles for potential ocular delivery. Pharmaceutics 2021,13(5),687","journal-title":"Pharmaceutics"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.ijbiomac.2020.12.211","volume":"171","author":"Telange D.R.","year":"2021","unstructured":"Telange D.R.; Jain S.P.; Pethe A.M.; Kharkar P.S.; Rarokar N.R.; Use of combined nanocarrier system based on chitosan nanoparticles and phospholipids complex for improved delivery of ferulic acid. Int J Biol Macromol 2021,171,288-307","journal-title":"Int J Biol Macromol"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1166\/jbn.2010.1154","volume":"6","author":"Chen M.","year":"2010","unstructured":"Chen M.; Liu X.; Fahr A.; Skin delivery of ferulic acid from different vesicular systems. J Biomed Nanotechnol 2010,6(5),577-585","journal-title":"J Biomed Nanotechnol"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.2147\/IJN.S206350","volume":"14","author":"Rezaei A.","year":"2019","unstructured":"Rezaei A.; Varshosaz J.; Fesharaki M.; Farhang A.; Jafari S.M.; Improving the solubility and in vitro cytotoxicity (anticancer activity) of ferulic acid by loading it into cyclodextrin nanosponges. Int J Nanomedicine 2019,14,4589-4599","journal-title":"Int J Nanomedicine"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.xphs.2019.12.002","volume":"109","author":"Chaves J\u00fanior J.V.","year":"2020","unstructured":"Chaves J\u00fanior J.V.; Dos Santos J.A.B.; Lins T.B.; de Ara\u00fajo Batista R.S.; de Lima Neto S.A.; de Santana Oliveira A.; Nogueira F.H.A.; Gomes A.P.B.; de Sousa D.P.; de Souza F.S.; Arag\u00e3o C.F.S.; A new ferulic acid-nicotinamide cocrystal with improved solubility and dissolution performance. J Pharm Sci 2020,109(3),1330-1337","journal-title":"J Pharm Sci"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"118986","DOI":"10.1016\/j.ijpharm.2019.118986","volume":"576","author":"Grimaudo M.A.","year":"2020","unstructured":"Grimaudo M.A.; Amato G.; Carbone C.; Diaz-Rodriguez P.; Musumeci T.; Concheiro A.; Alvarez-Lorenzo C.; Puglisi G.; Micelle-nanogel platform for ferulic acid ocular delivery. Int J Pharm 2020,576,118986","journal-title":"Int J Pharm"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3390\/nano11020425","volume":"11","author":"Mancuso A.","year":"2021","unstructured":"Mancuso A.; Cristiano M.C.; Pandolfo R.; Greco M.; Fresta M.; Paolino D.; Improvement of ferulic acid antioxidant activity by multiple emulsions: In vitro and in vivo evaluation. Nanomaterials (Basel) 2021,11(2),425","journal-title":"Nanomaterials (Basel)"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"101854","DOI":"10.1016\/j.jddst.2020.101854","volume":"59","author":"Rezaeiroshan A.","year":"2020","unstructured":"Rezaeiroshan A.; Saeedi M.; Morteza-Semnani K.; Akbari J.; Gahsemi M.; Nokhodchi A.; Development of trans-ferulic acid niosome: An optimization and in vivo study. J Drug Deliv Sci Technol 2020,59,101854","journal-title":"J Drug Deliv Sci Technol"}],"container-title":["Current Topics in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1568026622666220117105740","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/200278\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1568026622666220117105740","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T18:50:51Z","timestamp":1691866251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/200278\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":115,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568026622666220117105740","relation":{},"ISSN":["1568-0266"],"issn-type":[{"value":"1568-0266","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-07-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}